May 8 |
Pacira BioSciences, Inc. (PCRX) Q1 2024 Earnings Call Transcript
|
May 7 |
Pacira BioSciences Reports Q1 2024 Results: Aligns with EPS Projections and Announces $150 ...
|
May 7 |
Pacira BioSciences Non-GAAP EPS of $0.62, revenue of $167.11M
|
May 7 |
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
|
May 7 |
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
|
Apr 30 |
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
|
Apr 11 |
Pacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trend
|
Apr 4 |
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
|
Apr 2 |
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 14 |
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
|